Standardizing SANS in Spaceflight
NASA experts set out new diagnostic and management guidance for spaceflight-associated neuro-ocular syndrome
Clinical Scorecard: Standardizing SANS in Spaceflight
At a Glance
| Category | Detail |
|---|
| Condition | Spaceflight-Associated Neuro-Ocular Syndrome (SANS) |
| Key Mechanisms | Cephalad fluid shift, elevated intracranial pressure dynamics, impaired venous return, and altered glymphatic drainage. |
| Target Population | NASA astronauts on long-duration spaceflights. |
| Care Setting | Spaceflight missions beyond low Earth orbit. |
Key Highlights
- No established therapy exists for SANS; potential countermeasures are being explored.
Guideline-Based Recommendations
Diagnosis
- Use OCT to assess peripapillary retinal thickness and identify optic disc edema.
Management
- Refractive correction and return to Earth are primary management strategies.
Monitoring & Follow-up
- Standardized eye examinations and MRI before and after missions, with in-flight assessments.
Risks
- Hyperopic shift, central visual distortion, and potential long-term structural changes.
Patient & Prescribing Data
Current treatments are limited.
Clinical Best Practices
- Implement standardized diagnostic protocols for SANS.
Related Resources & Content
